HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alessandra Romano Selected Research
Alessandra Romano Research Topics
Disease
27
Multiple Myeloma
08/2023 - 01/2011
16
Neoplasms (Cancer)
10/2023 - 06/2011
12
Hodgkin Disease (Hodgkin's Disease)
02/2024 - 03/2015
10
COVID-19
01/2024 - 01/2022
6
Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 01/2020
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2021
4
Infections
09/2023 - 01/2020
3
Inflammation (Inflammations)
02/2023 - 07/2020
3
Primary Myelofibrosis (Myelosclerosis)
01/2023 - 04/2020
3
Neutropenia
08/2022 - 10/2019
2
Anemia
01/2024 - 12/2023
2
Breakthrough Infections
09/2023 - 01/2022
2
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2023 - 11/2019
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2023 - 09/2021
2
Residual Neoplasm
01/2023 - 01/2021
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023 - 01/2019
2
Leukemia
01/2023 - 01/2021
2
Disease Progression
01/2022 - 01/2021
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 01/2019
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014 - 03/2011
1
Gaucher Disease (Gaucher's Disease)
12/2023
1
Thrombocytopenia (Thrombopenia)
12/2023
1
Hematologic Diseases (Blood Diseases)
09/2023
1
Cataract (Cataracts)
07/2023
1
Anisometropia
07/2023
1
Retinal Detachment (Retinal Detachments)
07/2023
1
Polycythemia Vera
01/2023
1
Lymphoma (Lymphomas)
12/2022
1
Autosomal Dominant Rhegmatogenous Retinal Detachment
12/2022
1
Plasma Cell Neoplasms
12/2022
1
Coinfection
12/2022
1
Febrile Neutropenia
08/2022
1
COVID-19 breakthrough infections
01/2022
1
Systemic Mastocytosis
01/2022
1
Frailty
01/2022
Drug/Important Bio-Agent (IBA)
10
Lenalidomide (CC 5013)
FDA Link
08/2023 - 01/2018
7
Dexamethasone (Maxidex)
FDA Link
Generic
01/2024 - 02/2017
7
Cytokines
IBA
01/2022 - 06/2011
7
Bortezomib (Velcade)
FDA Link
01/2020 - 03/2011
5
Proteasome Inhibitors
IBA
04/2023 - 01/2018
4
Monoclonal Antibodies
IBA
09/2023 - 01/2021
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2021 - 01/2014
4
Brentuximab Vedotin
IBA
06/2020 - 10/2017
3
Vaccines
IBA
01/2023 - 01/2021
3
Melphalan (Alkeran)
FDA Link
Generic
12/2022 - 03/2011
3
pomalidomide
IBA
10/2021 - 02/2017
3
Vinblastine (Vinblastine Sulfate)
FDA Link
11/2020 - 10/2016
3
Dacarbazine (DIC)
FDA Link
Generic
11/2020 - 10/2016
3
Doxorubicin (Adriamycin)
FDA Link
Generic
11/2020 - 10/2016
3
Biomarkers (Surrogate Marker)
IBA
01/2019 - 03/2015
2
cilgavimab
IBA
09/2023 - 01/2023
2
tixagevimab
IBA
09/2023 - 01/2023
2
BNT162 Vaccine
IBA
01/2023 - 02/2022
2
1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)
IBA
10/2022 - 12/2021
2
Filgrastim (Neupogen)
FDA Link
08/2022 - 10/2019
2
Warfarin (Coumadin)
FDA Link
Generic
03/2021 - 03/2011
2
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
03/2021 - 03/2011
2
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
03/2021 - 03/2011
2
Immunomodulating Agents
IBA
03/2021 - 02/2017
2
Immunoconjugates (Immunoconjugate)
IBA
01/2021 - 01/2019
2
Bleomycin (Blenoxane)
FDA Link
Generic
11/2020 - 10/2016
2
Iron
IBA
01/2020 - 01/2019
2
Extracellular Matrix Proteins
IBA
11/2019 - 01/2014
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2014 - 03/2011
1
Immunoglobulin M (IgM)
IBA
02/2024
1
Hemoglobins (Hemoglobin)
IBA
12/2023
1
Enzymes
IBA
12/2023
1
Acids
IBA
12/2023
1
Glucosidases
IBA
12/2023
1
Antiviral Agents (Antivirals)
IBA
10/2023
1
nirmatrelvir and ritonavir drug combination
IBA
10/2023
1
molnupiravir
IBA
10/2023
1
Lactic Acid (Lactate)
FDA Link
Generic
04/2023
1
Buffers
IBA
02/2023
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
02/2023
1
Interleukin-6 (Interleukin 6)
IBA
02/2023
1
Calreticulin
IBA
01/2023
1
venetoclax
IBA
01/2023
1
Janus Kinase 2
IBA
01/2023
1
Messenger RNA (mRNA)
IBA
01/2023
1
COVID-19 Vaccines
IBA
01/2023
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2023
1
ruxolitinib
IBA
01/2023
1
blinatumomab
IBA
01/2023
1
hydroxyethyl methacrylate (HEMA)
IBA
12/2022
1
Pregnenolone Carbonitrile (PCN)
IBA
12/2022
1
pegfilgrastim (Neulasta)
FDA Link
08/2022
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
08/2022
1
Arginine (L-Arginine)
FDA Link
01/2022
1
Arginase
IBA
01/2022
Therapy/Procedure
19
Therapeutics
01/2024 - 01/2014
8
Drug Therapy (Chemotherapy)
01/2024 - 04/2013
3
Immunotherapy
01/2021 - 06/2011
2
Stem Cell Transplantation
01/2024 - 08/2023
2
Salvage Therapy
01/2024 - 01/2014
2
Radiotherapy
11/2020 - 10/2018
1
Vitrectomy
07/2023
1
Operative Time
07/2023
1
Phacoemulsification
07/2023
1
Activities of Daily Living (ADL)
01/2022